Tobias Sejbaek

15PUBLICATIONS
54CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)NaturopathyOptical technologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 05, 2026
Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.

|Jul 09, 2026
Neurofilament Light Chain in Cerebrospinal Fluid and Blood Identifies Patients With Minimal and Overt Hepatic Encephalopathy.

|Jun 19, 2026
Feasibility Study of an Early, Interdisciplinary, Non-Pharmacological Intervention for Patients at Risk of Developing Persistent Post-Traumatic Headache: The PTHEENOT intervention.

|Jan 28, 2026
A National Danish Effectiveness Study of Ocrelizumab Versus Natalizumab in Multiple Sclerosis.

Camilla Maersk-Moller, Luigi Pontieri, Morten Leif Munding Stilund

|Feb 27, 2025
Increased retinal thickness in sarcoidosis patients with ocular system involvement visualized with optical coherence tomography: a cross-sectional study.

Keld-Erik Byg, Torkell Ellingsen, Jimmi Wied

|Dec 23, 2024
Patterns and predictors of multiple sclerosis phenotype transition.

Luigi Pontieri, Nupur Greene, Malthe Faurschou Wandall-Holm

Pageof 3

Frequent Collaborators

5 joint publications

Zsolt Illes

3 joint publications

Finn Sellebjerg

3 joint publications

Henrik Boye Jensen

3 joint publications

Luigi Pontieri